UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Erratum to ‘Lipid Treatment and Goal Attainment Characteristics among Persons with Atherosclerotic Cardiovascular Disease in the United States’ [American Journal of Preventive Cardiology 1C (2020) 100010]

American journal of preventive cardiology, 2021-03, Vol.5, p.100160-100160, Article 100160

2021

Volltextzugriff (PDF)

Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan

Muscle & nerve, 2012-05, Vol.45 (5), p.676-683

2012

Volltextzugriff (PDF)

Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany

Atherosclerosis, 2018-01, Vol.268, p.99-107

2018

Volltextzugriff (PDF)

A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease

Orphanet journal of rare diseases, 2021-11, Vol.16 (1), p.1-460, Article 460

2021

Volltextzugriff (PDF)

Lifetime Costs for Treated Follicular Lymphoma Patients in the US

PharmacoEconomics, 2021-10, Vol.39 (10), p.1163-1183

2021

Volltextzugriff (PDF)

Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice

Atherosclerosis, 2018-04, Vol.271, p.120-127

2018

Volltextzugriff (PDF)

Lipid-lowering Therapy and Goal Achievement in High-risk Patients From French General Practice

Clinical therapeutics, 2018-09, Vol.40 (9), p.1484-1495.e22

2018

Volltextzugriff (PDF)

Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States

American journal of preventive cardiology, 2020-03, Vol.1, p.100010-100010, Article 100010

2020

Volltextzugriff (PDF)

Epidemiology of systemic sclerosis in a large US managed care population

Journal of rheumatology, 2012-04, Vol.39 (4), p.784-786

2012

Volltextzugriff (PDF)

Statin utilization and low-density lipoprotein cholesterol in statin-treated patients with atherosclerotic cardiovascular disease: Trends from a community-based health care delivery system, 2002–2016

Journal of clinical lipidology, 2020-05, Vol.14 (3), p.305-314

2020

Volltextzugriff (PDF)

Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease

Journal of health economics and outcomes research (Online), 2014-07, Vol.2 (1), p.63-74

2014

Volltextzugriff (PDF)

The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients

BMC health services research, 2014-12, Vol.14 (1), p.676-676, Article 676

2014

Volltextzugriff (PDF)

Medical costs and health-care resource use in patients with inflammatory myopathies in an insured population

Muscle & nerve, 2012-10, Vol.46 (4), p.496-505

2012

Volltextzugriff (PDF)

Preadmission glycemic control and changes to diabetes mellitus treatment regimen after hospitalization

Endocrine practice, 2012-05, Vol.18 (3), p.371-375

2012

Volltextzugriff (PDF)

Long-term clinical and economic outcomes associated with angiotensin II receptor blocker use in hypertensive patients

Current medical research and opinion, 2011-09, Vol.27 (9), p.1719-1731

2011

Volltextzugriff (PDF)

CONSISTENT LOW-DENSITY LIPOPROTEIN CHOLESTEROL LOWERING EFFICACY OF ALIROCUMAB IN HIGH AND VERY HIGH CARDIOVASCULAR RISK PATIENTS WITH LOW-DENSITY LIPOPROTEIN CHOLESTEROL >100/70 MG/DL AT BASELINE

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.1712-1712

2017

Volltextzugriff (PDF)

Annual medical costs and healthcare resource use in patients with systemic sclerosis in an insured population

Journal of rheumatology, 2012-12, Vol.39 (12), p.2303-2309

2012

Volltextzugriff (PDF)

Medical costs and healthcare resource use in patients with lupus nephritis and neuropsychiatric lupus in an insured population

Journal of medical economics, 2013-04, Vol.16 (4), p.500-509

2013

Volltextzugriff (PDF)

Abstract P128: Statin Prescribing, Switching, and Low-density Lipoprotein Cholesterol Goal Attainment Across Racial/Ethnic Groups With Atherosclerotic Cardiovascular Disease

Circulation (New York, N.Y.), 2019-03, Vol.139 (Suppl_1)

2019

Volltextzugriff (PDF)

Abstract 348: Marked Variability in the Patterns of Care and Health Outcomes among Patients Evaluated for Suspected Obstructive Coronary Artery Disease: Results from a Healthcare Claims Database Study of 12,129 Patients

Circulation Cardiovascular quality and outcomes, 2013-05, Vol.6 (suppl_1)

2013

Volltextzugriff (PDF)

Abstract 16967: Treatment Effect of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia With Baseline Low-density Lipoprotein Cholesterol Levels >130 mg/dL Receiving High Intensity Statin

Circulation (New York, N.Y.), 2016-11, Vol.134 (Suppl_1 Suppl 1), p.A16967-A16967

2016

Volltextzugriff (PDF)

Abstract 16974: Comparison of Low-density Lipoprotein Cholesterol Threshold Attainment With Alirocumab versus Ezetimibe Treatment in the ODYSSEY Program

Circulation (New York, N.Y.), 2016-11, Vol.134 (Suppl_1 Suppl 1), p.A16974-A16974

2016

Volltextzugriff (PDF)

Book Review: Statistical Group Comparison

Sociological Methods & Research, 2004, Vol.33 (2), p.309-312

Iorga, Şerban R.

2004

Volltextzugriff (PDF)

Statistical Group Comparison

Sociological Methods & Research, 2004, Vol.33 (2), p.309-312

Iorga, Serban R

2004

Volltextzugriff (PDF)

Applied longitudinal data analysis: modeling change and event occurrences

Sociological Methods & Research, 2004, Vol.33 (2), p.305-312

2004

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Erratum to ‘Lipid Treatment and Goal Attainment Characteristics among Persons with Atherosclerotic Cardiovascular Disease in the United States’ [American Journal of Preventive Cardiology 1C (2020) 100010]

Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan

Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany

A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease

Lifetime Costs for Treated Follicular Lymphoma Patients in the US

Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice

Lipid-lowering Therapy and Goal Achievement in High-risk Patients From French General Practice

Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States

Epidemiology of systemic sclerosis in a large US managed care population

Statin utilization and low-density lipoprotein cholesterol in statin-treated patients with atherosclerotic cardiovascular disease: Trends from a community-based health care delivery system, 2002–2016

Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease

The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients

Medical costs and health-care resource use in patients with inflammatory myopathies in an insured population

Preadmission glycemic control and changes to diabetes mellitus treatment regimen after hospitalization

Long-term clinical and economic outcomes associated with angiotensin II receptor blocker use in hypertensive patients

CONSISTENT LOW-DENSITY LIPOPROTEIN CHOLESTEROL LOWERING EFFICACY OF ALIROCUMAB IN HIGH AND VERY HIGH CARDIOVASCULAR RISK PATIENTS WITH LOW-DENSITY LIPOPROTEIN CHOLESTEROL >100/70 MG/DL AT BASELINE

Annual medical costs and healthcare resource use in patients with systemic sclerosis in an insured population

Medical costs and healthcare resource use in patients with lupus nephritis and neuropsychiatric lupus in an insured population

Abstract P128: Statin Prescribing, Switching, and Low-density Lipoprotein Cholesterol Goal Attainment Across Racial/Ethnic Groups With Atherosclerotic Cardiovascular Disease

Abstract 348: Marked Variability in the Patterns of Care and Health Outcomes among Patients Evaluated for Suspected Obstructive Coronary Artery Disease: Results from a Healthcare Claims Database Study of 12,129 Patients

Abstract 16967: Treatment Effect of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia With Baseline Low-density Lipoprotein Cholesterol Levels >130 mg/dL Receiving High Intensity Statin

Abstract 16974: Comparison of Low-density Lipoprotein Cholesterol Threshold Attainment With Alirocumab versus Ezetimibe Treatment in the ODYSSEY Program

Book Review: Statistical Group Comparison

Statistical Group Comparison

Applied longitudinal data analysis: modeling change and event occurrences

Suchergebnisse filtern